Proteomics: Clinical applications for head and neck squamous cell carcinoma
- 1 June 2006
- journal article
- review article
- Published by Wiley in Head & Neck
- Vol. 28 (6) , 549-558
Abstract
The emerging field of proteomics offers great promise for unraveling the complex molecular events of tumorigenesis, as well as those that control clinically important tumor behaviors such as metastases, invasion, and resistance to therapy. Understanding the molecular basis of these tumor characteristics will usher in a new age of individualized cancer therapy. Advances in genomics, the study of genes and gene expression, as well as technologic advances have made possible study of all expressed proteins or the proteome (proteomics). Whereas genomics offers the opportunity to examine gene expression or variation in gene sequence, proteomics encompasses evaluation of protein expression, activation, modification, and degradation and ambitiously targets protein function. Although the present age has already been referred to as the post‐genomic era, it is our opinion that both proteomics and genomics will provide clinically useful and complementary information that will speed scientific understanding of cancer. Ultimately, these new technologies will positively impact care of patients with head and neck squamous cell carcinoma. © 2006 Wiley Periodicals, Inc. Head Neck 28: 549–558, 2006Keywords
This publication has 19 references indexed in Scilit:
- The Use of Plasma Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Proteomic Patterns for Detection of Head and Neck Squamous Cell CancersClinical Cancer Research, 2004
- Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and NeckNew England Journal of Medicine, 2004
- Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck CancerNew England Journal of Medicine, 2004
- Analysis of Serum Proteomic Patterns for Early Cancer Diagnosis: Drawing Attention to Potential ProblemsJNCI: Journal of the National Cancer Institute, 2004
- Identification of Patients With Head and Neck Cancer Using Serum Protein ProfilesJAMA Otolaryngology–Head & Neck Surgery, 2004
- Molecular Assay to Detect Metastatic Head and Neck Squamous Cell CarcinomaJAMA Otolaryngology–Head & Neck Surgery, 2004
- Serum Protein MALDI Profiling to Distinguish Upper Aerodigestive Tract Cancer Patients From Control SubjectsJNCI: Journal of the National Cancer Institute, 2003
- Changes in the Protein Expression of Yeast as a Function of Carbon SourceJournal of Proteome Research, 2003
- Proteomic Patterns in Biological Fluids: Do They Represent the Future of Cancer Diagnostics?Clinical Chemistry, 2003
- Use of proteomic patterns in serum to identify ovarian cancerThe Lancet, 2002